Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Fitzpatrick scale

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    27 result(s) found for: Fitzpatrick scale. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2012-001296-36 Sponsor Protocol Number: PCTA206/11 Start Date*: 2012-03-09
    Sponsor Name:Photocure ASA
    Full Title: A double blinded, prospective, randomized, vehicle controlled, multi-center study of photodynamic therapy with Visonac cream in patients with acne vulgaris
    Medical condition: acne vulgaris
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2013-000629-30 Sponsor Protocol Number: 06022013 Start Date*: 2013-04-09
    Sponsor Name:Department of surgery, Herlev Hospital
    Full Title: The sun protective effect of melatonin: a randomized, placebo-controlled, double-blinded study on healthy volunteers.
    Medical condition: Erythema after sun exposure in healthy volunteers
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004858 10045745 Unspecified dermatitis due to sun LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-003610-86 Sponsor Protocol Number: EMCD1403 Start Date*: 2014-11-14
    Sponsor Name:
    Full Title: A double blind randomized controlled trial comparing the efficacy of 7% lidocaine / 7% tetracaine cream versus 2,5% lidocaine / 2,5% prilocaine cream for local anaesthesia during laser treatment of...
    Medical condition: Pain during laser treatment of: 1. Tattoo 2. Acne keloidalis nuchae
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-003552-48 Sponsor Protocol Number: AGO/2015/009 Start Date*: 2016-03-22
    Sponsor Name:Ghent University Hospital
    Full Title: Pilot trial to determine the efficacy of secukinumab in active non-segmental vitiligo
    Medical condition: Vitiligo
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2009-018191-34 Sponsor Protocol Number: FOL003 Start Date*: 2010-07-21
    Sponsor Name:Follica Inc.
    Full Title: A Study to Explore the Effect of Controlled Cutaneous Perturbation and Pharmacologic Modulation for Inducing Follicular Neogenesis
    Medical condition: Male subjects with androgenetic alopecia
    Disease: Version SOC Term Classification Code Term Level
    12.1 10068168 Androgenetic alopecia LLT
    Population Age: Adults Gender: Male
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2021-003608-41 Sponsor Protocol Number: RD.06.SPR.204245 Start Date*: 2022-01-12
    Sponsor Name:Galderma S.A.
    Full Title: Evaluation of acne-induced hyperpigmentation during treatment of acne vulgaris subjects with trifarotene 50 µg/g cream versus vehicle cream over 24 weeks.
    Medical condition: Moderate acne vulgaris with acne-induced post-inflammatory hyperpigmentation (PIH)
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004858 10000519 Acne vulgaris LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2004-001241-14 Sponsor Protocol Number: V00096 CR 201 Start Date*: 2004-11-12
    Sponsor Name:Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
    Full Title: Efficacy of topic RV3131A-HC3221 in the prevention of polymorphic light eruption
    Medical condition: Polymorphic Light Eruption (PMLE)
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed) DE (Completed) GB (Completed) SE (Completed)
    Trial results: View results
    EudraCT Number: 2006-004237-15 Sponsor Protocol Number: RD.03.SPR29057 Start Date*: 2007-03-06
    Sponsor Name:Galderma Research and Development
    Full Title: Comparison of Metvix® PDT with its vehicle in the treatment of photoaged skin
    Medical condition: Male and female subjects aged at least 30 years with a clinical diagnosis of photodamage (a score of at least 4 on the Griffiths photonumeric scale) and presence of mottled hyper-pigmentation on th...
    Disease: Version SOC Term Classification Code Term Level
    9.0 10064131 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2018-004397-96 Sponsor Protocol Number: CF20112018 Start Date*: 2019-04-09
    Sponsor Name:Merete Hædersdal
    Full Title: Impact of thermo-mechanical intervention on Protoporphyrin IX accumulation and biodistribution in normal skin following topical 5-aminolevulinic acid at high and low vehicle viscosity
    Medical condition: Healthy skin on the upper back on 3 participants in study a and 12 participants in study b.
    Disease: Version SOC Term Classification Code Term Level
    20.0 10022891 - Investigations 10022891 Investigations SOC
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2007-007315-93 Sponsor Protocol Number: V00071 GM 101 1A Start Date*: 2008-03-25
    Sponsor Name:Pierre Fabre dermatologie
    Full Title: Human skin blanching essay comparing a new shampoo containing betamethasone dipropionate at 0.025% and 0.050% to three reference marketed formulations in healthy subjects
    Medical condition: As it's a Mc Kensie and Stoughton test, there is no medical condition to be investigated in this trial. The intended indication for the betamethasone dipropionate shampoo is seborrhoeic dermatitis ...
    Disease:
    Population Age: Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2008-007173-20 Sponsor Protocol Number: V00071CR202 Start Date*: 2009-02-19
    Sponsor Name:Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
    Full Title: Assessment of the activity of a new cream containing betamethasone dipropionate at 0.010%, 0.025% and 0.050% versus reference products using a vasoconstriction assay in healthy subjects.
    Medical condition: Topical treatment of inflammatory dermatosis linked to cutaneous dryness
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2013-003501-25 Sponsor Protocol Number: ECM2013 Start Date*: 2014-02-20
    Sponsor Name:Mesoestetic Pharma group S.L.
    Full Title: Efficacy and safety of a 4% hydroquinone cream (Melanoderm 4%) for the treatment of melasma: a randomized controlled split-face study.
    Medical condition: Facial melasma
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004858 10027161 Melasma LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-000331-41 Sponsor Protocol Number: CHDR1430 Start Date*: 2016-03-22
    Sponsor Name:Centre for Human Drug Research
    Full Title: A randomized, open-label, vehicle-controlled, parallel, dose-ranging study to assess the pharmacodynamics of topically applied Imiquimod in healthy volunteers
    Medical condition: none, this is a study on healthy volunteers
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004858 10062249 Skin inflammation LLT
    Population Age: Adults Gender: Male
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-005672-13 Sponsor Protocol Number: CR-DER-3-07 (07E0274PH) Start Date*: 2007-12-28
    Sponsor Name:PALAU PHARMA SA
    Full Title: DOUBLE-BLIND STUDY, RANDOMISED, ACTIVE AND PLACEBO CONTROLLED TO ASSESS THE CLINICAL EFFICACY, SKIN TOLERABILITY AND PHARMACOLOGICAL ACTIVITY OF UR-1505 OINTMENT AT THREE DIFFERENT STRENGHTS IN PAT...
    Medical condition: Patients suffering from psoriasis with at least two eligible psoriatic plaques on equivalent topographic areas (arms, legs or trunk)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10037153 Psoriasis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-002003-14 Sponsor Protocol Number: TRI10/3.2006 Start Date*: 2006-08-30
    Sponsor Name:Winthrop Arzneimittel GmbH
    Full Title: Efficacy and tolerability of Triamcinolonacetonide crystalline solution for local treatment of keloids: clinical verum-controlled study in parallel groups with Triam 10 mg Lichtenstein versus Volon...
    Medical condition: Keloid
    Disease: Version SOC Term Classification Code Term Level
    8.1 10023330 Keloid scar LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-007981-44 Sponsor Protocol Number: RD.03.SPR.40076E Start Date*: 2009-03-12
    Sponsor Name:GALDERMA R&D SNC
    Full Title: EXPLORATORY STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CD5789 IN SUBJECTS WITH ACNE
    Medical condition: Acne vulgaris
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000519 Acne vulgaris LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2018-003436-74 Sponsor Protocol Number: 01-18/629-15 Start Date*: 2019-07-10
    Sponsor Name:Intas Pharmaceuticals Ltd
    Full Title: A Randomized, Double-Blind, Placebo-controlled, Three-arm, Parallel Assignment, Multi-Centre, Therapeutic Equivalence Study of Two Fluorouracil 5% Topical Cream Formulations in Adult Pat...
    Medical condition: Actinic Keratosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Prematurely Ended) RO (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2016-003197-41 Sponsor Protocol Number: DFD-29-CD-002 Start Date*: 2017-01-19
    Sponsor Name:Dr. Reddy's Labaratories Ltd.
    Full Title: A Multi-Center, Randomized, Double-Blind, Parallel-Group, Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules for the Treatment of Inflammatory...
    Medical condition: Inflammatory Lesions of papulopustular Rosacea
    Disease: Version SOC Term Classification Code Term Level
    20.0 10040785 - Skin and subcutaneous tissue disorders 10076537 Papulopustular rosacea PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2019-003567-21 Sponsor Protocol Number: CHDR1912 Start Date*: 2019-12-04
    Sponsor Name:Centre for Human Drug Research
    Full Title: A randomized, evaluator-blind, vehicle controlled, parallel group study to explore the effects of the anti-inflammatory drug prednisolone in a TLR4 and TLR7 challenge model in healthy volunteers
    Medical condition: None
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004858 10062249 Skin inflammation LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-002194-10 Sponsor Protocol Number: RV4421A2013147 Start Date*: 2014-11-10
    Sponsor Name:Pierre Fabre Dermo-Cosmétique
    Full Title: An intra-individual randomized controlled study to evaluate the efficacy and tolerance of the product RV4421A BS0042 in association with a moderately potent topical corticosteroid in adults with At...
    Medical condition: Atopic Dermatitis (arms, popliteal fossa)
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004858 10003639 Atopic dermatitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 15 11:12:39 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA